Description

VLHDDLLEA is a peptide that can be isolated from the MHC complex HLA-A*0201 molecule. VLHDDLLEA can be recognized by HLA-A*0201-restricted cytotoxic T cells (CTLs). VLHDDLLEA can be used for research on graft versus host disease (GvHD)[1].—–C45H73N11O16—-[1]den Haan JM, et al. The minor histocompatibility antigen HA-1: a diallelic gene with a single amino acid polymorphism. Science. 1998 Feb 13;279(5353):1054-7. d–204931-32-8–1024.13—-OC([C@H](C)NC([C@H](CCC(O)=O)NC([C@H](CC(C)C)NC([C@H](CC(C)C)NC([C@H](CC(O)=O)NC([C@H](CC(O)=O)NC([C@@H](NC([C@H](CC(C)C)NC([C@@H](N)C(C)C)=O)=O)CC1=CN=CN1)=O)=O)=O)=O)=O)=O)=O–Metabolic Disease–10 mM in DMSO–Others—-Others–Peptides